Boston Partners Gilead Sciences, Inc. Transaction History

Boston Partners

$77.5 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $252,432 - $287,634	-4,456 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.27 Million - $1.6 Million	-20,521 Reduced 82.16%	4,456 $282,000
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $71.4 Million - $82.9 Million	-986,335 Reduced 97.53%	24,977 $1.92 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $61.8 Million - $79.2 Million	-987,324 Reduced 49.4%	1,011,312 $75.6 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $13 Million - $14.3 Million	-211,567 Reduced 9.57%	1,998,636 $130 Million
Q3 2019 Nov 20, 2019	SELL	$62.51 - $69.0 $7.65 Million - $8.44 Million	-122,321 Reduced 5.24%	2,210,203 $140 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $437 - $483	-7 Reduced -0.0%	2,332,524 $158 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $221 Million - $248 Million	-3,572,977 Reduced 60.5%	2,332,531 $158 Million
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $132 Million - $148 Million	-2,113,207 Reduced 26.35%	5,905,508 $384 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $21.8 Million - $28.5 Million	-360,174 Reduced 4.3%	8,018,715 $502 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $6.3 Million - $6.98 Million	88,382 Added 1.07%	8,378,889 $647 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $15.9 Million - $18.6 Million	245,805 Added 3.06%	8,290,507 $587 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $19.8 Million - $24.2 Million	272,304 Added 3.5%	8,044,702 $606 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $189 Million - $222 Million	-2,652,391 Reduced 25.44%	7,772,398 $557 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $752 Million - $891 Million	10,424,789	10,424,789 $845 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account